The 3.2T DR8 PIC with 448G EAMs delivers clear benefits in power efficiency, cost, and time to production.”— Dr. Adam ...

Education company PhysicsWallah (PW) has announced the launch of Module 2.0, a re-engineered edition of its flagship academic study material for JEE and NEET aspirants. Designed in response to ...

Stellantis/Chrysler/FCA USA is recalling 456,287 trucks and SUVs over an improperly designed trailer tow module. The issue pertains to trailer lights which may fail to illuminate and, more seriously, ...

“Shrinking” has returned for Season 3, where viewers will sit down to watch these beloved characters undergo even more delightful, tear-jerky and absolutely hilarious adventures. And how does that ...

Previously presented at ESMO 2023, 177 Lu-PSMA-617 prolonged radiographic progression-free survival versus change of androgen receptor pathway inhibitor in taxane-naïve patients with mCRPC in PSMAfore ...

With a late-stage miss reported for its prospective social anxiety disorder (SAD) treatment fasedienol, Vistagen’s chances at an FDA approval in the indication are looking slimmer. That said, the ...

Have you ever wished for a tool that could not only simplify your daily tasks but also amplify your creativity and productivity? Enter Google Gemini 3, Google’s innovative AI assistant that’s ...

Findings showed treatment with tolebrutinib did not significantly delay disability progression compared with placebo. A phase 3 study evaluating tolebrutinib for the treatment of primary progressive ...

Share on Pinterest According to research, most people may not be getting enough omega-3 fatty acids in their diet. Image Credit: Tanja Ivanova/Getty Images A new research review reports that most ...

cDepartment of Clinical Oncology, State Key Laboratory of Translational Oncology, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Shatin, Hong Kong, Special Administrative Region, ...

- 48-week data show a 64% decrease from baseline in proteinuria in IgA nephropathy, 82% decrease from baseline in proteinuria in primary membranous nephropathy, and stabilization of estimated ...

The RELIEVE trial assesses remibrutinib's efficacy and safety in generalized myasthenia gravis, involving 180 participants in a 6-month double-blind study. Remibrutinib has shown a positive safety ...